Optimizing immunomodulatory therapy for MS patients: an integrated management model

J Neurol Sci. 2002 Sep 15;201(1-2):89-90. doi: 10.1016/s0022-510x(02)00195-8.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adjuvants, Immunologic / administration & dosage*
  • Drug Therapy / standards
  • Glatiramer Acetate
  • Humans
  • Interferon beta-1a
  • Interferon-beta / administration & dosage*
  • Multiple Sclerosis / drug therapy*
  • Peptides / administration & dosage*

Substances

  • Adjuvants, Immunologic
  • Peptides
  • Glatiramer Acetate
  • Interferon-beta
  • Interferon beta-1a